Stryker Other Long-Term Assets 2010-2024 | SYK
Stryker other long-term assets from 2010 to 2024. Other long-term assets can be defined as field containing the sum of all non-current assets that cannot be standardized into another field as well as those that are aggregated by the company because materially, they are too small to list separately.
- Stryker other long-term assets for the quarter ending September 30, 2024 were $2.833B, a 8.3% increase year-over-year.
- Stryker other long-term assets for 2023 were $2.673B, a 8.48% increase from 2022.
- Stryker other long-term assets for 2022 were $2.464B, a 8.88% increase from 2021.
- Stryker other long-term assets for 2021 were $2.263B, a 12.64% increase from 2020.
| Stryker Annual Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2023 | $2,673 |
| 2022 | $2,464 |
| 2021 | $2,263 |
| 2020 | $2,009 |
| 2019 | $1,671 |
| 2018 | $801 |
| 2017 | $1,301 |
| 2016 | $1,141 |
| 2015 | $1,151 |
| 2014 | $1,293 |
| 2013 | $494 |
| 2012 | $544 |
| 2011 | $537 |
| 2010 | $151 |
| 2009 | $137 |
| Stryker Quarterly Other Long-Term Assets (Millions of US $) |
|
|---|---|
| 2024-09-30 | $2,833 |
| 2024-06-30 | $2,790 |
| 2024-03-31 | $2,749 |
| 2023-12-31 | $2,673 |
| 2023-09-30 | $2,616 |
| 2023-06-30 | $2,648 |
| 2023-03-31 | $2,567 |
| 2022-12-31 | $2,464 |
| 2022-09-30 | $2,431 |
| 2022-06-30 | $2,419 |
| 2022-03-31 | $2,359 |
| 2021-12-31 | $2,263 |
| 2021-09-30 | $2,128 |
| 2021-06-30 | $2,114 |
| 2021-03-31 | $2,066 |
| 2020-12-31 | $2,009 |
| 2020-09-30 | $1,540 |
| 2020-06-30 | $1,499 |
| 2020-03-31 | $1,428 |
| 2019-12-31 | $1,671 |
| 2019-09-30 | $1,287 |
| 2019-06-30 | $1,223 |
| 2019-03-31 | $1,171 |
| 2018-12-31 | $801 |
| 2018-09-30 | $891 |
| 2018-06-30 | $853 |
| 2018-03-31 | $816 |
| 2017-12-31 | $1,301 |
| 2017-09-30 | $1,427 |
| 2017-06-30 | $1,203 |
| 2017-03-31 | $1,134 |
| 2016-12-31 | $1,141 |
| 2016-09-30 | $1,233 |
| 2016-06-30 | $1,150 |
| 2016-03-31 | $1,174 |
| 2015-12-31 | $1,151 |
| 2015-09-30 | $735 |
| 2015-06-30 | $731 |
| 2015-03-31 | $725 |
| 2014-12-31 | $1,293 |
| 2014-09-30 | $720 |
| 2014-06-30 | $530 |
| 2014-03-31 | $514 |
| 2013-12-31 | $494 |
| 2013-09-30 | $518 |
| 2013-06-30 | $554 |
| 2013-03-31 | $554 |
| 2012-12-31 | $544 |
| 2012-09-30 | $169 |
| 2012-06-30 | $158 |
| 2012-03-31 | $161 |
| 2011-12-31 | $537 |
| 2011-09-30 | $161 |
| 2011-06-30 | $162 |
| 2011-03-31 | $160 |
| 2010-12-31 | $151 |
| 2010-09-30 | $144 |
| 2010-06-30 | $136 |
| 2010-03-31 | $136 |
| 2009-12-31 | $137 |
| 2009-09-30 | $296 |
| 2009-06-30 | $300 |
| 2009-03-31 | $237 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $139.868B | $20.498B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $204.059B | 26.03 |
| Boston Scientific (BSX) | United States | $124.863B | 35.90 |
| Medtronic (MDT) | Ireland | $114.537B | 17.04 |
| EssilorLuxottica (ESLOY) | France | $110.799B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.365B | 0.00 |
| Haleon (HLN) | United Kingdom | $44.180B | 28.71 |
| GE HealthCare Technologies (GEHC) | United States | $39.743B | 20.61 |
| ResMed (RMD) | United States | $35.761B | 29.39 |
| Terumo (TRUMY) | Japan | $28.532B | 40.29 |
| Koninklijke Philips (PHG) | Netherlands | $25.454B | 19.48 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.582B | 13.74 |
| Baxter (BAX) | United States | $18.264B | 12.39 |
| Insulet (PODD) | United States | $16.648B | 70.04 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.052B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.282B | 35.10 |
| BellRing Brands (BRBR) | United States | $8.726B | 36.90 |
| Demant (WILYY) | Denmark | $8.351B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $8.016B | 19.24 |
| ICU Medical (ICUI) | United States | $4.201B | 40.09 |
| TG Therapeutics (TGTX) | United States | $3.771B | 0.00 |
| Haemonetics (HAE) | United States | $3.763B | 18.61 |
| Envista Holdings (NVST) | United States | $3.662B | 27.28 |
| Prestige Consumer Healthcare (PBH) | United States | $3.657B | 18.22 |
| Perrigo (PRGO) | Ireland | $3.466B | 10.95 |
| Neogen (NEOG) | United States | $3.127B | 36.08 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| GN Store Nord (GNNDY) | Denmark | $2.988B | 18.00 |
| QuidelOrtho (QDEL) | United States | $2.628B | 16.56 |
| Agios Pharmaceuticals (AGIO) | United States | $2.557B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.260B | 38.14 |
| LeMaitre Vascular (LMAT) | United States | $2.165B | 52.65 |
| Curaleaf Holdings (CURLF) | Canada | $2.023B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.960B | 0.00 |
| Warby Parker (WRBY) | United States | $1.769B | 0.00 |
| AtriCure (ATRC) | United States | $1.641B | 0.00 |
| InMode (INMD) | Israel | $1.460B | 8.78 |
| AdaptHealth (AHCO) | United States | $1.365B | 9.85 |
| Verano Holdings (VRNOF) | United States | $1.231B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.179B | 0.00 |
| Evolus (EOLS) | United States | $1.036B | 0.00 |
| Owens & Minor (OMI) | United States | $0.925B | 7.23 |
| National Vision Holdings (EYE) | United States | $0.915B | 29.08 |
| Phibro Animal Health (PAHC) | United States | $0.906B | 18.80 |
| CeriBell (CBLL) | United States | $0.893B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.844B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.747B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.542B | 16.36 |
| Surmodics (SRDX) | United States | $0.536B | 113.85 |
| Quanterix (QTRX) | United States | $0.532B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.515B | 0.00 |
| Valneva SE (VALN) | France | $0.475B | 0.00 |
| ZimVie (ZIMV) | United States | $0.398B | 33.56 |
| Viemed Healthcare (VMD) | United States | $0.331B | 35.54 |
| Aurora Cannabis (ACB) | Canada | $0.328B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.315B | 8.12 |
| TerrAscend (TSNDF) | Canada | $0.309B | 0.00 |
| Jin Medical (ZJYL) | China | $0.308B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.293B | 0.00 |
| Cerus (CERS) | United States | $0.290B | 0.00 |
| Biote (BTMD) | United States | $0.280B | 12.93 |
| Ayr Wellness (AYRWF) | United States | $0.279B | 0.00 |
| Zynex (ZYXI) | United States | $0.255B | 53.33 |
| Omeros (OMER) | United States | $0.246B | 0.00 |
| High Tide (HITI) | Canada | $0.234B | 97.00 |
| MacroGenics (MGNX) | United States | $0.232B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.225B | 15.14 |
| Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
| Brainsway (BWAY) | Israel | $0.172B | 206.40 |
| FitLife Brands (FTLF) | United States | $0.145B | 19.54 |
| Rockwell Medical (RMTI) | United States | $0.121B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.117B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.113B | 0.00 |
| Veru (VERU) | United States | $0.107B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.097B | 23.90 |
| Fonar (FONR) | United States | $0.092B | 9.51 |
| Jushi Holdings (JUSHF) | United States | $0.092B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.082B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.079B | 0.00 |
| InterCure (INCR) | Israel | $0.079B | 0.00 |
| Modular Medical (MODD) | United States | $0.073B | 0.00 |
| Safety Shot (SHOT) | United States | $0.065B | 0.00 |
| Sanuwave Health (SNWVD) | United States | $0.064B | 1.63 |
| MariMed (MRMD) | United States | $0.062B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.045B | 0.00 |
| Exagen (XGN) | United States | $0.043B | 0.00 |
| Apyx Medical (APYX) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.028B | 0.00 |
| Flora Growth (FLGC) | United States | $0.020B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Nephros (NEPH) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.013B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.006B | 0.00 |
| Agape ATP (ATPC) | $0.006B | 0.00 | |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Senestech (SNES) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 17.87 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |